The following is a summary of “Impact of Race on Sacubitril/Valsartan use of HF,” published in the October 2024 issue of Cardiology by Lu et al. There is limited understanding of how self-reported ...

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...

Novartis exceeded analyst expectations in the third quarter, driven primarily by the strong U.S. sales of Cosentyx, as well ...

The PARADIGM-HF and PARAGON-HF trials demonstrated consistent benefits of sacubitril/valsartan relative to RAS inhibitors in ...

You may qualify for a study at the University of Alabama at Birmingham exploring the effects of sacubitril/valsartan on your ...

Use of sacubitril/valsartan compared to other RAS inhibitors demonstrated similar benefit across race categories. For all race categories, risk of severe angioedema was low but numerically higher with ...

A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...

Sacubitril/valsartan may be a better treatment option compared with ACEi/ARBs for patients with malignant hypertension-associated thrombotic microangiopathy. Kidney recovery is better when thrombotic ...

A federal judge rejected Novartis Pharmaceuticals Corp.’s motion to declare as unlawful the FDA’s approval of a rival version of its heart failure drug Entresto. In the sealed memorandum, the judge ...

Sacubitril/valsartan significantly reduces NT-proBNP levels in patients with heart failure with reduced ejection fraction (HFrEF) over 3 years, with no significant changes in sST2 and galectin-3.

Just as more extreme weather swept over Norway's west coast last week, a new brochure was landing in Norwegians' mailboxes. It's part of further efforts to boost individual preparedness for various ...

This advertisement has not loaded yet, but your article continues below. Randy Boissonnault must answer questions about why a company that he co-owned said it was Indigenous-owned while bidding on ...